Victory Capital Management
ATOS icon

Victory Capital Management’s Atossa Therapeutics ATOS Stock Holding History

Victory Capital Management’s Portfolio ATOS Stock Details ATOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-991
Closed -$12.9K – 2432
2025
Q3 		$12.9K Sell
991
-35
-3% -$432 ﹤0.01% 2409
2025
Q2 		$12.8K Buy
1,026
+15
+1% +$179 ﹤0.01% 2466
2025
Q1 		$10.2K Sell
1,011
-26
-3% -$316 ﹤0.01% 2452
2024
Q4 		$14.7K Sell
1,037
-27
-3% -$527 ﹤0.01% 2460
2024
Q3 		$24.3K Sell
1,064
-16
-1% -$323 ﹤0.01% 2430
2024
Q2 		$19.3K Buy
+1,080
New +$23.9K ﹤0.01% 2434
2023
Q4 		– Sell
-922
Closed -$10.2K – 2541
2023
Q3 		$10.2K Sell
922
-2
-0.2% -$29 ﹤0.01% 2485
2023
Q2 		$17.5K Sell
924
-22
-2% -$267 ﹤0.01% 2457
2023
Q1 		$10.3K Sell
946
-12
-1% -$134 ﹤0.01% 2546
2022
Q4 		$7.59K Hold
958
– – ﹤0.01% 2555
2022
Q3 		$12K Sell
958
-86
-8% -$1.25K ﹤0.01% 2648
2022
Q2 		$17K Sell
1,044
-7
-0.7% -$110 ﹤0.01% 2628
2022
Q1 		$16K Sell
1,051
-103
-9% -$2.09K ﹤0.01% 2650
2021
Q4 		$28K Sell
1,154
-36
-3% -$1.32K ﹤0.01% 2672
2021
Q3 		$58K Sell
1,190
-41
-3% -$2.38K ﹤0.01% 2676
2021
Q2 		$117K Buy
1,231
+495
+67% +$26.2K ﹤0.01% 2583
2021
Q1 		$23K Buy
+736
New +$26.9K ﹤0.01% 2713
2020
Q2 		– Sell
-207
Closed -$4K – 2568
2020
Q1 		$4K Buy
+207
New +$4.07K ﹤0.01% 3509
2019
Q4 		– Sell
-109
Closed -$3K – 2686
2019
Q3 		$3K Buy
+109
New +$3.45K ﹤0.01% 3545

Other funds holding ATOS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Victory Capital Management's ATOS Position: Q4 2025 in Review

Victory Capital Management sold out of Atossa Therapeutics (ATOS) in Q4 2025, closing a stake of 991 shares — an estimated $12.9K sold.

Victory Capital Management first reported a position in ATOS in Q3 2019 and held it in 19 quarters. The position peaked at $117K in Q2 2021. 67 funds tracked by Wall St. Rank hold ATOS as of Q4 2025.

  • Victory Capital Management reported no remaining Atossa Therapeutics position as of Q4 2025 after selling out during the quarter.
  • Victory Capital Management sold 991 Atossa Therapeutics shares in Q4 2025, an estimated $12.9K.
  • Victory Capital Management first reported a position in Atossa Therapeutics in Q3 2019 and held it in 19 quarters.
  • Victory Capital Management's Atossa Therapeutics position peaked at $117K in Q2 2021.
  • 67 funds tracked by Wall St. Rank held Atossa Therapeutics as of Q4 2025.

Based on Victory Capital Management's 13F filing for Q4 2025, filed 13 Feb 2026.